(Reuters) – Britain’s medicines regulator on Friday approved Pfizer Inc’s COVID-19 pill, Paxlovid, for people over the age of 18 years with mild to moderate illness who are at high risk of developing severe COVID-19.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D’Silva)
